SCHMERTZLER MICHAEL sold 1.5% of their position (20K shares) of PTC THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.35M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 9/11/2026ACC: 0001288952-26-000008
Director
Since Jan 2019
-20K
Net shares
Net seller
$1.35M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
20K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−9.43K
Price / share
$67.79
Trade value
$639.12K
% of position
0.7%
9/9/2026
1.34M→1.33M
Common Stock
Indirect
Shares
−572.00
Price / share
$68.67
Trade value
$39.28K
% of position
0.0%
9/9/2026
1.33M→1.33M
Common Stock
Indirect
Shares
−10K
Price / share
$67.34
Trade value
$673.40K
% of position
0.8%
9/10/2026
1.33M→1.32M
Total
Net shares
−20K
Net value
-$1.35M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/9/2026 | S · Sale | −9.43K | $67.79 | $639.12K | 0.7% | 1.34M | 1.33M |
| Common Stock Indirect | 9/9/2026 | S · Sale | −572.00 | $68.67 | $39.28K | 0.0% | 1.33M | 1.33M |
| Common Stock Indirect | 9/10/2026 | S · Sale | −10K | $67.34 | $673.40K | 0.8% | 1.33M | 1.32M |
| Total | −20K | -$1.35M | ||||||
Derivative Transactions0
No derivative transactions reported